• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于基孔肯雅病毒感染潜在治疗的小干扰RNA的设计

Design of therapeutic siRNAs for potential application to infection with chikungunya virus.

作者信息

Adib Ahmed Ahsan, Karim Muhammad Manjurul

机构信息

Department of Microbiology, University of Dhaka, Dhaka, 1100, Bangladesh.

出版信息

Heliyon. 2025 Jan 10;11(2):e41824. doi: 10.1016/j.heliyon.2025.e41824. eCollection 2025 Jan 30.

DOI:10.1016/j.heliyon.2025.e41824
PMID:39897885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11782961/
Abstract

Emergence of the Chikungunya virus (CHIKV) is a new threat in the world. The disastrous effect of this virus and the unavailability of specific drugs complicated the control and management of the disease. The development of a siRNA-based drug using multiple computational tools could be a way out as one of its therapeutics. Currently, very few siRNAs against CHIKV have been computationally designed and published. Here, we considered various parts of the CHIKV genome encoding different essential protein-coding genes for designing siRNAs with a view to silencing them, thereby rendering the virus inactive. Seven potential primary siRNAs were constructed, of which, five are hereafter recommended to be used as a therapeutic tool against the virus.

摘要

基孔肯雅病毒(CHIKV)的出现是全球面临的新威胁。该病毒造成的灾难性影响以及缺乏特效药物,使疾病的控制和管理变得复杂。利用多种计算工具开发基于小干扰RNA(siRNA)的药物可能是一种治疗方法。目前,通过计算设计并发表的针对CHIKV的siRNA非常少。在此,我们考虑了CHIKV基因组中编码不同必需蛋白质编码基因的各个部分,以设计siRNA来沉默这些基因,从而使病毒失去活性。我们构建了7种潜在的初级siRNA,其中5种在此推荐作为对抗该病毒的治疗工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3112/11782961/3fb23d261228/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3112/11782961/568392834a67/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3112/11782961/043a4899bbad/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3112/11782961/21a1fbb5e4ea/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3112/11782961/3fb23d261228/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3112/11782961/568392834a67/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3112/11782961/043a4899bbad/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3112/11782961/21a1fbb5e4ea/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3112/11782961/3fb23d261228/gr4.jpg

相似文献

1
Design of therapeutic siRNAs for potential application to infection with chikungunya virus.用于基孔肯雅病毒感染潜在治疗的小干扰RNA的设计
Heliyon. 2025 Jan 10;11(2):e41824. doi: 10.1016/j.heliyon.2025.e41824. eCollection 2025 Jan 30.
2
Targeted gene silencing of E2 and nsP1 genes of chikungunya virus by biocompatible zeolitic imidazolate framework.通过生物相容性沸石咪唑酯骨架对基孔肯雅病毒的E2和nsP1基因进行靶向基因沉默。
Front Bioeng Biotechnol. 2022 Dec 14;10:1003448. doi: 10.3389/fbioe.2022.1003448. eCollection 2022.
3
Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus.给予 E2 和 NS1 siRNA 可抑制体外的基孔肯雅病毒复制,并保护感染该病毒的小鼠。
PLoS Negl Trop Dis. 2013 Sep 5;7(9):e2405. doi: 10.1371/journal.pntd.0002405. eCollection 2013.
4
Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.锌盐和镁盐抗基孔肯雅病毒的抗病毒潜力研究:治疗意义。
Front Cell Infect Microbiol. 2024 Jun 4;14:1335189. doi: 10.3389/fcimb.2024.1335189. eCollection 2024.
5
RNA interference mediated inhibition of Chikungunya virus replication in mammalian cells.RNA干扰介导的对基孔肯雅病毒在哺乳动物细胞中复制的抑制作用。
Biochem Biophys Res Commun. 2008 Nov 28;376(4):718-22. doi: 10.1016/j.bbrc.2008.09.040. Epub 2008 Sep 19.
6
The Host DHX9 DExH-Box Helicase Is Recruited to Chikungunya Virus Replication Complexes for Optimal Genomic RNA Translation.宿主 DHX9 DExH-Box 解旋酶被招募到基孔肯雅病毒复制复合物中以进行最佳基因组 RNA 翻译。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01764-18. Print 2019 Feb 15.
7
RNAi-Induced Gene Silencing against Chikungunya and COVID-19: What Have We Learned So Far, and What Is the Way Forward?RNAi 诱导的基对基因沉默对基孔肯雅热和 COVID-19:我们迄今为止学到了什么,以及未来的路是什么?
Viruses. 2024 Sep 20;16(9):1489. doi: 10.3390/v16091489.
8
Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.血清素能药物在细胞进入途径的不同阶段抑制基孔肯雅病毒感染。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00274-20.
9
Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication.基孔肯雅病毒感染的人类肌肉细胞的蛋白质组学分析:揭示细胞骨架网络在基孔肯雅病毒复制中的作用
J Proteomics. 2014 Aug 28;108:445-64. doi: 10.1016/j.jprot.2014.06.003. Epub 2014 Jun 14.
10
DNA Damage Response Signaling Is Crucial for Effective Chikungunya Virus Replication.DNA 损伤反应信号对有效复制基孔肯雅病毒至关重要。
J Virol. 2022 Dec 14;96(23):e0133422. doi: 10.1128/jvi.01334-22. Epub 2022 Nov 15.

本文引用的文献

1
antiviral activity of formulations against dengue virus type 2 and chikungunya viruses.制剂对登革热2型病毒和基孔肯雅病毒的抗病毒活性。
Heliyon. 2022 Nov 30;8(12):e11879. doi: 10.1016/j.heliyon.2022.e11879. eCollection 2022 Dec.
2
Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera.通过人血清的被动转移证明 CHIKV 疫苗 VLA1553 的有效性。
JCI Insight. 2022 Jul 22;7(14):e160173. doi: 10.1172/jci.insight.160173.
3
Demystifying therapeutic potential of medicinal plants against chikungunya virus.
揭开药用植物治疗基孔肯雅病毒潜力的神秘面纱。
Indian J Pharmacol. 2021 Sep-Oct;53(5):403-411. doi: 10.4103/ijp.IJP_81_20.
4
Endemic and Indigenous Plants from Mascarene Islands with Antiviral Propensities.具有抗病毒倾向的马斯克林群岛的地方特有植物和本土植物。
Curr Drug Targets. 2022;23(1):72-86. doi: 10.2174/1389450122666210824143910.
5
Designing and evaluation of MERS-CoV siRNAs in HEK-293 cell line.设计和评价中东呼吸综合征冠状病毒 siRNAs 在 HEK-293 细胞系中的作用。
J Infect Public Health. 2021 Feb;14(2):238-243. doi: 10.1016/j.jiph.2020.12.018. Epub 2020 Dec 29.
6
Antiviral Natural Products for Arbovirus Infections.抗病毒天然产物抗虫媒病毒感染。
Molecules. 2020 Jun 17;25(12):2796. doi: 10.3390/molecules25122796.
7
Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial.单次减毒活寨卡病毒疫苗在健康成年人中的应用:一项 1 期、随机对照试验。
Lancet Infect Dis. 2020 Oct;20(10):1193-1203. doi: 10.1016/S1473-3099(20)30238-3. Epub 2020 Jun 1.
8
The HDOCK server for integrated protein-protein docking.HDOCK 服务器:用于整合蛋白质-蛋白质对接
Nat Protoc. 2020 May;15(5):1829-1852. doi: 10.1038/s41596-020-0312-x. Epub 2020 Apr 8.
9
Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine.具有完整衣壳缺失的感染性基孔肯雅病毒(CHIKV):一种新型的基孔肯雅病毒疫苗。
J Virol. 2019 Jul 17;93(15). doi: 10.1128/JVI.00504-19. Print 2019 Aug 1.
10
Evaluation of medicinal herbs for Anti-CHIKV activity.草药抗 CHIKV 活性评价。
Virology. 2019 Jul;533:45-49. doi: 10.1016/j.virol.2019.04.007. Epub 2019 Apr 29.